Skip to main content
Toggle navigation
Login
Search
Home
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Email
Tweet
Daniel L. Van Dyke, PhD
Consultant in Genomics
Mayo Clinic
N/A
Poster(s):
1122 - Treatment Patterns and Outcomes of Patients with TP53-Mutated Chronic Lymphocytic Leukemia
1134 - High deletion burden identified by whole genome sequencing is associated with enhanced risk in del17p CLL patients
1160 - Clinical outcomes in patients with chronic lymphocytic leukemia (CLL) treated with venetoclax-based regimens
Email Daniel
